Pharmaceutical removal by the activated carbon process

Water Quality Research Journal of Canada

Volumn 48, Issue 2, 2013, Pages 121-132

  Piel, S ^a,b,c   Blondeau, S ^c   Perot J ^c   Baures E ^a,b   Thomas, O ^a,b  

^a EHESP Rennes ^*  (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c SAUR   (France)

Author keywords

Activated carbon; Adsorption; Pharmaceuticals; Water

Indexed keywords

CARBAMAZEPINE; PHARMACEUTICAL PRODUCTS; POWDERED ACTIVATED CARBON; REMOVAL EFFICIENCIES; REMOVAL RATE; SAMPLING CAMPAIGNS; SULFAMETHOXAZOLE; TARGET MOLECULE;

ADSORPTION; AMIDES; CAFFEINE; DRUG PRODUCTS; FLUIDIZATION; MOLECULES; WATER;

ACTIVATED CARBON;

ACTIVATED CARBON; ADSORPTION; DRUG; FLUIDIZATION; POLLUTANT REMOVAL; SURFACE WATER; WATER TREATMENT;

BRETAGNE; FRANCE; VILAINE BASIN;

EID: 84876585814     PISSN: 12013080     EISSN: None     Source Type: Journal    
DOI: 10.2166/wqrjc.2013.138     Document Type: Article

References (22)

1. Boleda, M. R., Galceran, M. T. & Ventura, F. 2011 Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ. Pollut. 159, 1584-1591.
2. De Ridder, D. J., McConville, M., Verliefde, A. R. D., Van Der Aa, L. T. J., Heijman, S. G. J., Verberk, J. Q. J. C., Rietveld, L. C. & Van Dijk, J. C. 2009 Development of a predictive model to determine micropollutant removal using granular activated carbon. Drinking Water Eng. Sci. 2, 57-62.
3. Fent, K., Weston, A. A. & Caminada, D. 2006 Ecotoxicoloy of human pharmaceuticals. Aquat. Toxicol. 76, 122-159.
4. Huerta-Fontela, M., Galceran, M. T. & Ventura, F. 2008 Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ. Sci. Technol. 42, 6809-6816.
5. Huerta-Fontela, M., Galceran, M. T. & Ventura, F. 2011 Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res. 45, 1432-1442.
6. Institut d'Aménagement de la Vilaine 2003 Etude monographique des fleuves et grandes rivières de France (Monographic Study of Rivers in France). Report IAV, http://www.eptb.asso.fr/documentation-1/etude-monographique/Vilaine.pdf (accessed 20 December 2011).
7. Jones-Lepp, T. L. & Stevens, R. 2007 Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation. Analyt. Bioanalyt. Chem. 387, 1173-1183.
8. Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J. & Snyder, S. A. 2007 Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 41, 1013-1021.
9. Kümmerer, K. 2009 The presence of pharmaceuticals in the environment due to human use: present knowledge and future challenges. J. Environ. Manage. 90, 2354-2366.
10. Mompelat, S., Thomas, O. & Le Bot, B. 2011 Contamination level of human pharmaceutical products in French surface and drinking water. J. Environ. Monit. 13, 2929-2939.
11. Newcombe, G. & Dixon, D. (eds) 2006 Interface Science in Drinking Water Treatment: Theory and Applications. Academic Press, Oxford, UK.
12. NF EN 1484 1997 Analyse de l'eau: Lignes directrices pour le dosage du carbone organique total (COT) et carbone organique dissous (COD) (Water Analysis: Guidelines for Determination of Total Organic Carbon (TOC) and Dissolved Organic Carbon (DOC).
13. Observatoire eau Bretagne 2009 La qualité de l'eau potable en 2009 (Drinking Water Quality in 2009). Report OEB, http://www.bretagne-environnement.org/Eau/Qualite-et-quantite/La-qualite-de-l-eau-potable (accessed 20 December 2011).
14. Official Journal of the European Community 1998 Directive 98/83/EC on the Quality of Water Intended for Human Consumption (3 November 1998), http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1998:330:0032:0054:FR:PDF (accessed 20 December 2011).
15. Snyder, S. A., Adham, S., Redding, A. M., Cannon, F. S., DeCarolis, J., Oppenheimer, J., Wert, E. C. & Yoon, Y. 2007a Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202, 156-181.
16. Snyder, S. A., Wert, E. C., Lei, H., Westerhoff, P. & Yoon, Y. 2007b Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes. AWWA Research Foundation Report, Denver, CO.
17. Stackelberg, P. E., Gibs, J., Furlong, E. T., Meyer, M. T., Zaugg, S. D. & Linpincott, R. L. 2007 Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 377 (2-3), 255-272.
18. Ternes, T. A., Janex-Habibi, M. L., Knacker, T., Kreuzinger, N. & Siegrist, H. 2004 Poseidon project: Asssessment of Technologies for the Removal of Pharmaceuticals and Personal Care Products in Sewage and Drinking Water Facilities to Improve the Indirect Potable Water Reuse. EVK1-CT-2000-00047.
19. Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Bauch, H. J. & Haist-Gulde, B. 2002 Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36, 3855-3863.
20. Vieno, N. M., Härkki, H., Tuhkanen, T. & Kronberg, L. 2007 Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 41, 5077-5084.
21. Wenzel, H., Larsen, H. F., Clauson-Kaas, J., Høibye, L. & Jacobsen, B. N. 2008 Weighing environmental advantages and disadvantages of advanced wastewater treatment of micro-pollutants using environmental life cycle assessment. Water Sci. Technol. 57, 27-32.
22. Westerhoff, P., Yoon, Y., Snyder, S. & Wert, E. 2005 Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 39, 6649-6663.